heterozygous familial hypercholesterolemia

Related by string. Heterozygous Familial Hypercholesterolemia * Heterozygous : heterozygous FH . heterozygous familial / Familial : familial aggregation . familial predisposition / Hypercholesterolemia : homozygous familial hypercholesterolemia . mediated amyloidosis ATTR hypercholesterolemia * heterozygous familial hypercholesterolemia heFH . heterozygous familial hypercholesterolemia HeFH *

Related by context. Frequent words. (Click for all words.) 65 elevated LDL cholesterol 63 familial hypercholesterolemia 60 retinal vein occlusion 59 attention-deficit/hyperactivity disorder ADHD 59 Dasatinib 59 elevated triglycerides 59 primary hypercholesterolemia 58 olmesartan 58 diabetic neuropathic pain 58 density lipoprotein HDL cholesterol 58 darapladib 58 hypercholesterolemia 57 lupus nephritis 57 serum uric acid 56 juvenile idiopathic arthritis 56 pulmonary arterial hypertension 56 ocrelizumab 56 ximelagatran 56 secondary hyperparathyroidism 56 Arch Intern Med 55 hypertriglyceridemia 55 fasting glucose levels 55 grade glioma 55 pancreatic insufficiency 55 diabetic macular edema DME 55 arterial thrombosis 55 grade gliomas 55 non alcoholic steatohepatitis 55 nondiabetic 55 Mipomersen 55 dyslipidemia 54 losartan 54 uncontrolled hypertension 54 metastatic hormone refractory 54 Atacand 54 MEK inhibitor 54 tofacitinib 54 taranabant 54 mixed dyslipidemia 54 Duchenne muscular dystrophy DMD 54 pravastatin 54 lipid lowering therapy 54 cholesterol lowering statins 54 myelodysplastic syndrome MDS 54 osteoarthritis rheumatoid arthritis 54 idiopathic pulmonary fibrosis IPF 54 Amrubicin 54 AAT deficiency 54 venous thromboembolic events 54 ependymoma 54 hyperparathyroidism 54 Phenoptin 53 glitazones 53 teplizumab 53 primary pulmonary hypertension 53 heavily pretreated 53 cholesterol LDL C 53 hypoparathyroidism 53 atopic eczema 53 placebo controlled Phase 53 systemic lupus erythematosus 53 blood clotting disorder 53 AstraZeneca Crestor 53 acne vulgaris 53 double blinded placebo 53 candesartan 53 pramlintide 53 normotensive 53 serum calcium 53 hereditary angioedema 53 Leber congenital amaurosis 53 myeloproliferative disorders 53 LY# [003] 53 neurogenic orthostatic hypotension 53 acute myelogenous leukemia AML 53 lipid lowering drugs 53 placebo controlled clinical 53 precocious puberty 52 figitumumab 52 renal toxicity 52 acute myeloid leukemia AML 52 angiotensin receptor blockers 52 optic neuropathy 52 cholesterol lowering medicines 52 phase IIb clinical 52 malignant pleural mesothelioma 52 pulmonary arterial hypertension PAH 52 infantile spasms 52 irbesartan 52 elevated cholesterol 52 senicapoc 52 liprotamase 52 elotuzumab 52 thyroid tumors 52 Age Related Macular 52 salicylates 52 phenylketonuria 52 Heplisav 52 Cozaar 52 AREDS 52 Diamyd ®

Back to home page